The Medical City’s Department of Nuclear Medicine provides both diagnostic and therapeutic procedures for various organ systems through the use of radioactive substances. This branch of medicine highly involves the administration of radioactive substances to diagnose and treat diseases. The services are provided by Nuclear Medicine physicians and technologists trained in the safe use of radiopharmaceuticals for imaging and for treatment of a wide-spectrum of disease entities. Generally, Nuclear Medicine procedures are safe, non-invasive, and do not cause any discomfort to the patients.
Services
Nuclear Cardiology
A. Myocardial Perfusion Stress Testing
Treadmill
Dipyridamole
Dobutamine
Adenosine
B. MUGA (Cardiac Gated Blood Pool Study)
C. Infarct Avid Scintigraphy
D. SPECT TI201 – Tc99m Sestamibi Dual Isotope Studies
Radionuclide Therapy
A. Iodine131 Therapy for Toxic Goiter
Diffuse
Nodular
B. Iodine131 Therapy for Thyroid Cancer
C. Iodine131 MIBG
D. P32 for Polycythemia Vera
E. Selective Internal Radiation Therapy using Yttrium90
Intrahepatic Arterial MAA Breakthrough Scan
Yttrium90 Post Implantation Bremsstrahlung Scan
F. Radionuclide Bone Palliation using Samarium153
G. Radionuclide Bone Palliation using Strontium89
Dual Energy X-Ray Absorptiometry
A. Bone Densitometry
Central
Appendicular
Whole Body
B. Body Composition
C. Pediatrics
D. Vertebral Fracture Assessment
Radioimmunoassay
Free T3
Free T4
TSH
Thyroglobulin
TSH Receptor Antibody
Anti-Thyroglobulin Antibody and Thyroid Peroxidase (Antithyroid Microsomal Antibody)
Intact PTH (Parathyroid Hormone)
ACTH (Adrenocorticotropic Hormone)
Human Growth Hormone
Free Testosterone
Plasma Renin
Aldosterone
DHT (α-dihydrotestosterone)
Insulin-like growth factor 1
General Nuclear Medicine Scintigraphy
A. CNS (Central Nervous System)
HMPAO Brain Scan
Brain Perfusion using DTPA
B. Endocrine
Thyroid Scintigraphy using Tc99m and Iodine131
Thyroid Uptake using Tc99m and Iodine-131
Parathyroid Scintigraphy Dual Phase
Parathyroid Scintigraphy Dual Isotope (Tl201 and Tc99m)
Parathyroid Scintigraphy using Tc99m and Tc99m Sestamibi
Liver Scintigraphy with SPECT using Tc99m Sulfur Colloid
Liver Scintigraphy with SPECT using PYP for Hemangioma
Heat Damaged Spleen Scintigraphy
C. Respiratory
Lung Perfusion
Lung Ventilation using Tc99m DTPA Aerosol
D. Gastrointestinal
Gastric Emptying
Gastro Esophageal Reflux
Hepatobiliary Scintigraphy (HIDA)
Meckel’s Diverticulum Scintigraphy
G.I. Bleed Study (RBC Tagging) using PYP
Urea Breath Test
E. Genito-Urinary
Renal Scintigraphy using Tc99m DTPA
Renal Scintigraphy using Tc99m MAG3
Glomerular Filtration Rate using Gates Method
Plasma Clearance using Tc99m DTPA (In-Vitro GFR)
Renal Scintigraphy Diuretic Challenge
Renal Scintigraphy Captopril Challenge
Direct Cystography
Indirect Cystography
Testicular Blood Flow Scintigraphy
F. Miscellaneous
Salivary Gland Scintigraphy
Dacryoscintigraphy
Pleuroperitoneal Shunt Study
Ventriculo-peritoneal Study
Tc99m MAA Lung and Brain Scintigraphy in Hepatopulmonary Syndrome
Indium111 Octreotide
Tc99m-DTPA Octreotide
Radionuclide Cisternogram
Iodine131 MIBG Whole Body Scintigraphy
1Gallium67 Whole Body Scan with SPECT
Iodine131 Whole Body Scintigraphy
Indium111 WBC Scintigraphy
Lymphoscintigraphy
Sentinel Lymph Node Mapping (Melanoma and Breast Cancer)
Intra-operative Gamma Probe-guided Sentinel Node Biopsy
Scintimmamography
Thallium201 Whole Body Scintigraphy
G. Skeletal System
Whole Body Scan with SPECT
Triple-phase Bone Scan
SPECT-CT
TMC has acquired the first and only SPECT-CT or Single Photon Emission Computed Tomography-Computed Tomography in the country.
The Symbia T16 TruePoint SPECT-CT is a revolutionary diagnostic modality that provides a more precise, more reliable, and earlier diagnosis, thus significantly improving the patient’s chance of being cured. It offers increased speed over the other Symbia systems.
This high technology equipment can complete a full rotation in 0.5 seconds, yielding particular benefits for oncology screening when a large area must be covered in a short time. The system’s rapid scan time also makes it ideal for calcium scoring, providing detailed images of the coronary arteries in less than 20 seconds, irrespective of the heart beat.
UPDATES
Additional procedures
Tc99m-DTPA Octreotide
The test is for the diagnosis and staging of persons with primary and metastatic neuroendocrine tumors bearing somatostatin receptors. Such tumors include any of the following:
Carcinoid tumors/carcinoid syndrome
Gastrinomas
Glucagonomas
Insulinomas
Islet cell tumors of the pancreas
Medullary thyroid carcinoma (MTC)
Neuroendocrine carcinoma of the rectum
Paragangliomas
Pheochromocytomas
Pituitary adenomas
Tumor-induced osteomalacia (oncogenic osteomalacia) (for diagnosis only)
VIPoma (vasoactive intestinal peptide) - persons present with Verner-Morrison syndrome: watery diarrhea, hypokalemia and achlorhydria
Radionuclide Cisternogram
This test determines if there is abnormal cerebrospinal fluid (CSF) flow within the brain and spinal canal termed hydrocephalus. It may also evaluate a suspected leak (also known as a CSF fistula) from the CSF cavity into the nasal cavity
Our Team
Dr. Angel M. De Guzman - Chief Consultant
Visiting Consultants
Dr. Edward-Bengie L. Magsombol (Nuclear Cardiologist)
Dr. Christopher A.G. Carbonell
Dr. Eddie A. Lim
Dr. Michele D. Ogbac
Dr. Eduardo Erasto S. Ongkeko
Dr. Enrique Leonardo P. Ote
The Medical City’s Department of Nuclear Medicine is located on the Lower Ground, Podium Bldg.
Operating Hours:
8:00 AM -7:00 PM Monday to Friday
8:00 AM – 12:00 NN Saturday
OFF Sunday
Phone:
8-988-1000 / 8-988-7000 locals 6130 / 6131
Email:
Phone:
Email: